Appendix C. List of organisations involved in this appraisal

The following organisations are consultees/commentators in this appraisal. Consultees are also invited to appeal against the Final Appraisal Determination.

I) Professional/specialist and patient/carer groups:

Association of Cancer Physicians
Association of Surgeons of Great Britain and Ireland
British Association of Surgical Oncology
British Oncological Association
British Oncology Pharmacy Association (BOPA)
British Psychosocial Oncology Society (BPOS)
Cancer Research UK
Community Practitioners' & Health Visitors' Association
Medical Women's Federation
Royal of General Practitioners
Royal College
Royal of Pathologists
Royal of Physicians' Medical Oncology Joint Special Committee
Royal of Radiologists
Royal of Surgeons
Royal Pharmaceutical Society
Breakthrough Breast Cancer
Breast Cancer Campaign
Breast Cancer Care
Cancer Voices
Cancerbackup
Long-term Medical Conditions Alliance
Macmillan Cancer Relief
Marie Curie Cancer Care
National Cancer Alliance
National Council for Palliative Care
Tenovus Cancer Information Centre

II) Commentator organisations (without the right of appeal):

Board of Community Health Councils in Wales
British National Formulary
Medicines and Healthcare products Regulatory Agency (MHRA)
National Public Health Service for Wales
NHS Confederation
NHS Purchasing and Supplies Agency
NHS Quality Improvement Scotland
Baxter Healthcare Ltd
Bayer plc
Bristol-Myers Squibb Pharmaceuticals Ltd
Genus Pharmaceuticals
GlaxoSmithKline
Goldshield Pharmaceuticals Ltd
Kyowa Hakko UK Ltd
Mayne Pharma plc
Medac UK
Pfizer Ltd [Pharmacia]
Pierre Fabre Ltd
Roche Products Ltd
Sanofi-Aventis
Schering-Plough Ltd
Wyeth Pharmaceuticals
Cochrane Collaboration – Cochrane Breast Cancer Group
Institute Research
MRC Clinical Trials Unit
National Cancer Research Institute
National Coordinating Centre for Health Technology Assessment
Southampton Health Technology Assessment Centre
National Collaborating Centre for Cancer